Latest news
AI-empowered pipeline-in-a-drug option: Insilico Medicine nominates ISM9077, potential first-in-class target Y inhibitor, as preclinical candidate (PCC) for ocular diseases, inflammatory disorders and aging - eurekalert.orgeurekalert.org · Thu, 06 Aug 2026 02:25:40 GMTAnthropic Incident Shows Why Healthcare AI Needs Stronger Oversight - Telehealth.orgTelehealth.org · Wed, 05 Aug 2026 08:00:00 GMTTech Leaders Meet White House on Optional AI Safety - Briefs FinanceBriefs Finance · Mon, 03 Aug 2026 21:48:13 GMTNew CREST AI Standards to Deliver AI-Enabled Pentesting Accreditation - Infosecurity MagazineInfosecurity Magazine · Tue, 28 Jul 2026 07:00:00 GMT